By Roland Sebestyén
The very first informational cannabis campaign that aims to educate the public on the Endocannabinoid System has been approved in the UK.
Endo Agency, a strategy, branding, & digital cannabis design solution specialist, kicked off its campaign in London after the Advertising Standards Authority (ASA) & Committees of Advertising Practice (CAP) approved a plan for an educational cannabis message to be advertised in the public domain.
The two-week campaign launched this week in “multiple prime Central London locations,” such as Westminster, Trafalgar Square, and Oxford Street.
Marwan Elgamal, the founder of THC ® & Endo, said: “For years cannabis companies have struggled to make any footprint through paid advertising, with very few brands able to have their campaigns cleared even globally.
“Confidence is starting to grow however, with the ASA & CAP allowing us to officially submit, and challenge old restrictions currently stopping the rest of the industry, we are confident of a new wave of growth for space.”
Helaku Whyles, the Co-Founder of Endo, added: “Allowing these new forms of advertising media helps the communication of complex ideas to become intelligible and comprehensive, by breaking the psychological shackles disallowing potential consumers the right to make well-informed decisions.”
As we reported a few weeks ago, a Finnish beverages company, YSUB, was aiming to raise awareness of strict cannabis laws in place in the EU and the Nordic/Scandinavian countries with a striking advertising campaign.
YSUB’s product cannot currently be bought in stores or online in Finland due to current legislation. In response to these restrictions, YSUB’s “Not for sale” ad campaign has been put on 54 billboards around the country’s capital city, Helsinki.
Hopefully, ASA’s and CAP’s decision could set a precedent and pave the way for medical cannabis and CBD ad campaigns in Europe as well.